Previous 10 | Next 10 |
Summary Two new Breakout Stocks for Week 39 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now down to +108.7% YTD. This week no picks beat 10% gains in less than a week with SLCR peak at +7.1% and continuing the highest negative Mom...
Wave Life Sciences ( NASDAQ: WVE ) said a single dose of 30 mg or 60 mg WVE-003 helped reduce mutant huntingtin (mHTT) protein in cerebrospinal fluid (CSF) in patients with Huntington's disease (HD) who are in the early stages and carry SNP3 in association wit...
Single doses of WVE-003 appear generally safe and well-tolerated CSF mutant huntingtin (mHTT) protein was reduced following single doses of 30 or 60 mg; mean mHTT reduction across both cohorts was 22% (median reduction 30%) from baseline 85 days post-single dose Wild-type ...
CAMBRIDGE, Mass., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced it will hold an analyst and investor webcast on Wednesd...
Neptune Wellness Solutions ( NEPT ) +48% . ADDvantage Technologies Group ( AEY ) +33% Technologies GAAP EPS of $0.07, revenue of $27.79M. Larimar Therapeutics ( LRMR ) +31% on plans to resolve clinical hold on lead asset. Twin Vee Powercats ...
There was a great deal of life in Wave Life Sciences (NASDAQ: WVE) stock on Thursday. As of midafternoon trading, investors had bid the company's share price up by more than 25%, comparing very favorably to the marginal gain eked out by the S&P 500 index. That was due almost...
Wave Life Sciences Ltd. (WVE) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Kate Rausch - Head, Investor Relations Paul Bolno - President and Chief Executive Officer Mike Panzara - Chief Medical Officer Head, Therapeutics Discov...
Gainers: Digital Media Solutions ( DMS ) +133% . FlexShopper ( FPAY ) +72% . Absci ( ABSI ) +58% . Timber Pharmaceuticals ( TMBR ) +50% . T2 Biosystems ( TTOO ) +37% . Wave Life Sciences ( WVE ) +36% . Veru ( VE...
The following slide deck was published by Wave Life Sciences Ltd. in conjunction with their 2022 Q2 earnings call. For further details see: Wave Life Sciences Ltd. 2022 Q2 - Results - Earnings Call Presentation
Wave Life Sciences press release ( NASDAQ: WVE ): Q2 GAAP EPS of -$0.62 misses by $0.08 . Revenue of $0.37M (-86.7% Y/Y). As of June 30, 2022, Wave had $148.2 million in cash, cash equivalents and short-term investments For further details see:...
News, Short Squeeze, Breakout and More Instantly...
Wave Life Sciences Ltd. Company Name:
WVE Stock Symbol:
NASDAQ Market:
Wave Life Sciences Ltd. Website:
2024-07-17 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Statistically significant, potent, and durable allele-selective silencing: 46% mean reduction in CSF mutant huntingtin (mHTT) protein compared to placebo, preservation of wild-type huntingtin (wtHTT) protein, and generally safe and well-tolerated profile achieved in 30 mg multidose cohort ...
Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and the opportunity for Wave’s INHBE program as a best-in-class approach for obesity designed to induce fat burning and preserve muscle mass with once or twice-annual sub...